Silver Book Fact

Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.

Xu Z, Zhang L, Liu T, Park J, et al. Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions. Nature Med. 2010; 16(5): 592-7. http://www.nature.com/nm/journal/v16/n5/full/nm.2123.html

Reference

Title
Resolvins RvE1 and RvD1 Attenuate Inflammatory Pain Via Central and Peripheral Actions
Publication
Nature Med
Publication Date
2010
Authors
Xu Z, Zhang L, Liu T, Park J, et al
Volume & Issue
Volume 16, Issue 5
Pages
592-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.  
  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.  
  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.